SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Damon Pham who wrote (410)4/12/1997 10:30:00 PM
From: tony echols   of 849
 
Damon,

I agree about the long term potential for this company. I suspect that insiders have been selling to protect some profits from the run up the stock had last year. It may be true that the stock will drift down a bit more, particularly considering the current sell off in the overall markets. However, the basic reasons the stock was driven upward last year are still true today. NMPS has a technology with the potential to benefit mankind greatly once the tests are developed and approved for general screening as a normal part of preventive health care. Barring some unforseen shortcoming in this technology, the day will come when the earnings potential of its application will be reflected in the stock price. With this perspective, I have to view the current weakness as a buying opportunity for those with patience and a strong stomach .
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News